United States
Statement summary
Trump announces pharmaceutical import tariffs with phased implementation and conditional exceptions
Trump announces pharmaceutical import tariffs under Proclamation 11020 with phased implementation and conditional exceptions.
Title 3— The President Proclamation 11020 of April 2, 2026 Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States By the President of the United States of America A Proclamation 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his investigation into the effects of imports of pharmaceuticals and pharmaceutical ingredients on the national security of the United States under section 232 of the Trade Expansion Act of 1962, as amended, 19 U.S.C. 1862 (section 232). Based on the facts considered in that investigation, and taking into account the close relation of the economic welfare of the Nation to our national security and other relevant factors, see 19 U.S.C. 1862(d), the Secretary found and advised me of his opinion that pharmaceuticals and associated active pharmaceutical ingredients (APIs), including key starting...